DK1121116T3 - Farmaceutisk præparat af fluvastatin med opretholdt frigivelse - Google Patents

Farmaceutisk præparat af fluvastatin med opretholdt frigivelse

Info

Publication number: DK1121116T3
Authority: DK; Denmark
Prior art keywords: sustained; release; pharmaceutical composition; fluvastatin; fluvastatin pharmaceutical
Prior art date: 1998-10-14

Application number

DK99947489T

Other languages

English (en)

Inventor

Rajen Shah

Arun P Patel

Roy T Sandry

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-14

Filing date

1999-10-12

Publication date

2008-05-13

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22627919&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1121116(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-10-12 Application filed by Novartis Ag filed Critical Novartis Ag

2008-05-13 Application granted granted Critical

2008-05-13 Publication of DK1121116T3 publication Critical patent/DK1121116T3/da

Links

FJLGEFLZQAZZCD-MCBHFWOFSA-N (3R,5S)-fluvastatin Chemical compound C12=CC=CC=C2N(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)=C1C1=CC=C(F)C=C1 FJLGEFLZQAZZCD-MCBHFWOFSA-N 0.000 title 1
229960003765 fluvastatin Drugs 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
238000013268 sustained release Methods 0.000 title 1
239000012730 sustained-release form Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Obesity (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Anesthesiology (AREA)
Psychiatry (AREA)
Vascular Medicine (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK99947489T 1998-10-14 1999-10-12 Farmaceutisk præparat af fluvastatin med opretholdt frigivelse DK1121116T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US17249198A	1998-10-14	1998-10-14
PCT/EP1999/007627 WO2000021525A2 (en)	1998-10-14	1999-10-12	Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent

Publications (1)

Publication Number	Publication Date
DK1121116T3 true DK1121116T3 (da)	2008-05-13

Family

ID=22627919

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99947489T DK1121116T3 (da)	1998-10-14	1999-10-12	Farmaceutisk præparat af fluvastatin med opretholdt frigivelse

Country Status (30)

Country	Link
EP (1)	EP1121116B1 (da)
JP (2)	JP2002527388A (da)
KR (1)	KR100517090B1 (da)
CN (1)	CN1196481C (da)
AR (2)	AR020780A1 (da)
AT (1)	ATE382345T1 (da)
AU (1)	AU765475B2 (da)
BR (1)	BR9911648A (da)
CA (1)	CA2346868C (da)
CO (1)	CO5140079A1 (da)
CY (1)	CY1107874T1 (da)
DE (1)	DE69937891T2 (da)
DK (1)	DK1121116T3 (da)
ES (1)	ES2297936T3 (da)
HK (1)	HK1040920B (da)
HU (1)	HUP0104268A3 (da)
ID (1)	ID29350A (da)
IL (2)	IL142375A0 (da)
MY (1)	MY121105A (da)
NO (1)	NO327285B1 (da)
NZ (1)	NZ511010A (da)
PE (1)	PE20001110A1 (da)
PL (1)	PL198850B1 (da)
PT (1)	PT1121116E (da)
RU (1)	RU2259826C2 (da)
SK (2)	SK286595B6 (da)
TR (1)	TR200101088T2 (da)
TW (1)	TW577738B (da)
WO (1)	WO2000021525A2 (da)
ZA (1)	ZA200103001B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6569461B1 (en)	1999-03-08	2003-05-27	Merck & Co., Inc.	Dihydroxy open-acid and salts of HMG-CoA reductase inhibitors
US6242003B1 (en) *	2000-04-13	2001-06-05	Novartis Ag	Organic compounds
ATE418979T2 (de)	2000-06-09	2009-01-15	Lek Pharmaceuticals	Stabilisiertes arzneimittel und arzneizubereitung
ES2284709T3 (es) *	2000-09-29	2007-11-16	Solvay Pharmaceuticals B.V.	Formulacion farmaceutica de liberacion sostenida independiente de la fuerza ionica.
US20060127474A1 (en)	2001-04-11	2006-06-15	Oskar Kalb	Pharmaceutical compositions comprising fluvastatin
WO2004024184A1 (ja) *	2002-09-11	2004-03-25	Takeda Pharmaceutical Company Limited	徐放性製剤
JP2007523664A (ja)	2003-04-23	2007-08-23	フェリングベスローテンフェンノートシャップ	医薬組成物用サシェ
US8987322B2 (en)	2003-11-04	2015-03-24	Circ Pharma Research And Development Limited	Pharmaceutical formulations for carrier-mediated transport statins and uses thereof
DE102004062475A1 (de) *	2004-12-24	2006-07-06	Bayer Healthcare Ag	Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
KR100582347B1 (ko) *	2004-12-30	2006-05-22	한미약품 주식회사	3-하이드록시-3-메틸글루타릴 조효소 ａ 환원효소 억제제및 고혈압 치료제의 복합제제 및 그의 제조방법
CA2615941A1 (en) *	2005-08-05	2007-02-15	Orbus Pharma Inc.	Stabilized extended release pharmeceutical compositions comprising an hmg-coa reductase inhibitor
BRPI0708191A2 (pt) *	2006-02-24	2012-05-29	Teva Pharma	" composições farmacêuticas de fluvastatina sódica "
RU2342144C1 (ru) *	2007-04-05	2008-12-27	Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН")	Фармацевтический состав, обладающий противосудорожным и психотропным действием
RU2356532C2 (ru) *	2007-06-01	2009-05-27	Открытое Акционерное Общество "Отечественные Лекарства"	Фармацевтическая композиция проксодолола с контролируемым высвобождением
CN102805739B (zh) *	2012-04-10	2013-08-14	宋芸	氟伐他汀钠缓释包衣滴丸及其制备方法
EP2943186A1 (en) *	2013-01-09	2015-11-18	Edgemont Pharmaceuticals LLC	Controlled release formulations of lorazepam
CN106344535B (zh) *	2016-08-29	2019-09-20	济南康和医药科技有限公司	一种氟伐他汀钠微孔渗透泵控释片及其制备方法
CN118593482A (zh)	2017-12-05	2024-09-06	赛诺维信制药公司	非外消旋混合物及其用途
WO2019113084A1 (en)	2017-12-05	2019-06-13	Sunovion Pharmaceuticals Inc.	Crystal forms and production methods thereof
US11802103B2 (en)	2018-09-25	2023-10-31	Ponce De Leon Health Designated Activity Company	Process of making calcium alpha-ketoglutarate
MX2021014774A (es)	2019-06-04	2022-02-03	Sunovion Pharmaceuticals Inc	Formulaciones de liberacion modificada y usos de las mismas.
EP3980001B1 (en) *	2019-06-10	2025-08-27	Ponce de Leon Health Designated Activity Company	Sustained-release compositions of alpha-ketoglutarate

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4915954A (en) *	1987-09-03	1990-04-10	Alza Corporation	Dosage form for delivering a drug at two different rates
CA2045428A1 (en) *	1990-06-26	1991-12-27	Alfred W. Alberts	Method for enhancing the lowering of plasma cholesterol levels
ZA959221B (en) *	1994-11-02	1997-04-30	Janssen Pharmaceutica Nv	Cisapride extended release
US5798375A (en) *	1995-07-03	1998-08-25	Sankyo Company, Limited	Treatment of arteriosclerosis and xanthoma
GB9523752D0 (en) *	1995-11-21	1996-01-24	Pfizer Ltd	Pharmaceutical formulations
DE69625046T2 (de) *	1995-12-22	2003-04-10	Kowa Co., Ltd.	Pharmazeutische zusammensetzung stabilisiert mit einem basischen medium
SE9603667D0 (sv) *	1996-10-08	1996-10-08	Astra Ab	Pharmaceutical compositions

1999
- 1999-10-05 CO CO99062951A patent/CO5140079A1/es unknown
- 1999-10-12 PT PT99947489T patent/PT1121116E/pt unknown
- 1999-10-12 CN CNB998120812A patent/CN1196481C/zh not_active Expired - Lifetime
- 1999-10-12 AU AU60909/99A patent/AU765475B2/en not_active Expired
- 1999-10-12 EP EP99947489A patent/EP1121116B1/en not_active Revoked
- 1999-10-12 PE PE1999001027A patent/PE20001110A1/es not_active IP Right Cessation
- 1999-10-12 WO PCT/EP1999/007627 patent/WO2000021525A2/en not_active Ceased
- 1999-10-12 HK HK02102698.9A patent/HK1040920B/zh not_active IP Right Cessation
- 1999-10-12 CA CA002346868A patent/CA2346868C/en not_active Expired - Lifetime
- 1999-10-12 IL IL14237599A patent/IL142375A0/xx unknown
- 1999-10-12 DE DE69937891T patent/DE69937891T2/de not_active Expired - Lifetime
- 1999-10-12 BR BR9911648-0A patent/BR9911648A/pt not_active Application Discontinuation
- 1999-10-12 TR TR2001/01088T patent/TR200101088T2/xx unknown
- 1999-10-12 ES ES99947489T patent/ES2297936T3/es not_active Expired - Lifetime
- 1999-10-12 RU RU2001111882/15A patent/RU2259826C2/ru active
- 1999-10-12 AR ARP990105146A patent/AR020780A1/es not_active Application Discontinuation
- 1999-10-12 HU HU0104268A patent/HUP0104268A3/hu not_active Application Discontinuation
- 1999-10-12 PL PL348109A patent/PL198850B1/pl unknown
- 1999-10-12 SK SK509-2001A patent/SK286595B6/sk not_active IP Right Cessation
- 1999-10-12 NZ NZ511010A patent/NZ511010A/en not_active IP Right Cessation
- 1999-10-12 SK SK5054-2008A patent/SK286596B6/sk not_active IP Right Cessation
- 1999-10-12 DK DK99947489T patent/DK1121116T3/da active
- 1999-10-12 AT AT99947489T patent/ATE382345T1/de active
- 1999-10-12 ID IDW20010807A patent/ID29350A/id unknown
- 1999-10-12 JP JP2000575501A patent/JP2002527388A/ja active Pending
- 1999-10-12 KR KR10-2001-7004708A patent/KR100517090B1/ko not_active Expired - Lifetime
- 1999-10-13 MY MYPI99004430A patent/MY121105A/en unknown
- 1999-10-14 TW TW088117692A patent/TW577738B/zh not_active IP Right Cessation
2001
- 2001-04-02 IL IL142375A patent/IL142375A/en not_active IP Right Cessation
- 2001-04-04 NO NO20011695A patent/NO327285B1/no not_active IP Right Cessation
- 2001-04-11 ZA ZA200103001A patent/ZA200103001B/en unknown
2006
- 2006-08-14 JP JP2006221194A patent/JP4938383B2/ja not_active Expired - Fee Related
2008
- 2008-02-04 CY CY20081100134T patent/CY1107874T1/el unknown
- 2008-11-11 AR ARP080104921A patent/AR069281A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
DE69937891T2 (de)	2008-12-11
CA2346868C (en)	2008-09-09
NZ511010A (en)	2003-10-31
SK286595B6 (sk)	2009-01-07
EP1121116B1 (en)	2008-01-02
HUP0104268A3 (en)	2002-06-28
ATE382345T1 (de)	2008-01-15
ZA200103001B (en)	2002-07-11
CA2346868A1 (en)	2000-04-20
JP4938383B2 (ja)	2012-05-23
NO20011695L (no)	2001-05-30
CO5140079A1 (es)	2002-03-22
NO327285B1 (no)	2009-06-02
RU2259826C2 (ru)	2005-09-10
PE20001110A1 (es)	2000-11-01
TR200101088T2 (tr)	2001-10-22
JP2006298945A (ja)	2006-11-02
ES2297936T3 (es)	2008-05-01
AR069281A2 (es)	2010-01-13
AU6090999A (en)	2000-05-01
CN1196481C (zh)	2005-04-13
HK1040920A1 (en)	2002-06-28
AU765475B2 (en)	2003-09-18
HK1040920B (zh)	2005-07-29
ID29350A (id)	2001-08-23
EP1121116A2 (en)	2001-08-08
KR20010080156A (ko)	2001-08-22
IL142375A (en)	2012-01-31
JP2002527388A (ja)	2002-08-27
CY1107874T1 (el)	2013-06-19
TW577738B (en)	2004-03-01
PT1121116E (pt)	2008-03-12
BR9911648A (pt)	2001-03-20
SK286596B6 (sk)	2009-01-07
CN1328454A (zh)	2001-12-26
HUP0104268A2 (hu)	2002-04-29
KR100517090B1 (ko)	2005-09-27
PL348109A1 (en)	2002-05-06
PL198850B1 (pl)	2008-07-31
MY121105A (en)	2005-12-30
SK5092001A3 (en)	2001-09-11
DE69937891D1 (de)	2008-02-14
IL142375A0 (en)	2002-03-10
WO2000021525A2 (en)	2000-04-20
NO20011695D0 (no)	2001-04-04
AR020780A1 (es)	2002-05-29
WO2000021525A3 (en)	2000-08-10

Publication	Publication Date	Title
ID27415A (id)	2001-04-05	Komposisi farmaseutik
IS5046A (is)	1999-11-16	Lyfjasamsetningar
ID22891A (id)	1999-12-16	Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
PT1066027E (pt)	2003-12-31	Composicao farmaceutica de topiramato
NO20015175D0 (no)	2001-10-23	Farmasöytisk sammensetning
NO20005913L (no)	2001-01-22	Legemiddelsammensetning
ID29262A (id)	2001-08-16	Komposisi farmasi
ID18352A (id)	1998-04-02	Komposisi-komposisi farmasi
NO992692L (no)	1999-12-06	Nefadozon doseringsform
FI991302A7 (fi)	1999-06-08	Parannetut farmaseuttiset koostumukset
DK1466615T3 (da)	2009-08-31	Farmaceutisk præparat
ID27201A (id)	2001-03-08	Komposisi farmasi
ID21009A (id)	1999-04-08	Komposisi untuk supositori
ID27150A (id)	2001-03-08	Sediaan levotiroksin bahan farmasi
EE9900440A (et)	2000-04-17	Farmatseutilised kompositsioonid
PT941100E (pt)	2003-10-31	Composicoes farmaceuticas
EE200000330A (et)	2001-08-15	Farmatseutilised kompositsioonid
FI4488U1 (fi)	2000-07-20	Farmaseuttinen koostumus
EE200100281A (et)	2002-08-15	Analgeetiline ravimkoostis
EP1124557A4 (en)	2002-08-07	Pharmaceutical composition
ID26215A (id)	2000-12-07	Komposisi farmasi
FI961364L (fi)	1997-09-26	Lääkeainekoostumus
ITMI962628A0 (it)	1996-12-16	Composizione farmaceutica
NO994436L (no)	1999-09-13	Farmasöytiske sammensetninger
SE9800330D0 (sv)	1998-02-05	Pharmaceutical compositions